Inogen

StarFish Contribution

StarFish Medical partnered with Inogen to help develop the first portable oxygen concentrator, handling industrial design, mechanical engineering, and the creation of functional prototypes. This collaboration focused on miniaturizing components to create a lightweight and portable device, which involved redesigning many parts to make them functional and manufacturable.

$100M Valuation

Inogen’s IPO in 2014 valued the company at over $350 million, with continued growth as a leading global provider of innovative respiratory care solutions. The company’s products have helped transform the standard care for patients requiring long-term oxygen therapy.